Skip to main content
GLP1 Clinics

THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

GLP-1 clinical trial results
The Dose

Lilly's GLP-1 Pill Foundayo Beats Oral Semaglutide in Diabetes Trials, FDA Filing Next

Eli Lilly's oral GLP-1 pill Foundayo outperformed Novo Nordisk's oral semaglutide in head-to-head diabetes trials, setting up a second FDA submission by month's end.

The Dose·
Editorial cartoon: trending up arrow on teal/yellow waves
The Dose

Scientists Find Way to Extend GLP-1 Weight Loss, Break Drug Plateaus

By The Dose·

Editorial cartoon: pill capsule on green wave illustration
The Dose

Bariatric Surgery Plunges 34% as GLP-1 Drugs Surge 140% in Historic Shift

By GLP1 Clinics News Desk·

Editorial cartoon: lab flask with cross on teal/blue shapes
The Dose

GLP-1 Drugs May Prevent Cancer from Spreading, Major Study Finds

By GLP1 Clinics News Desk·

Editorial cartoon: lab flask with cross on teal/blue shapes
The Dose

Retatrutide Shows Record 28% Weight Loss in Breakthrough Phase 3 Trial

By The Dose·